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We have isolated a full-length cDNA (HPAsn.6) for human placenta glycosylasparaginase using a 221-bp PCR amplified fragment containing rat 
liver asparaginase gene sequences. The deduced amino acid sequence from the human clone showed sequence identity to both the a and/J subunits 
of the rat enzyme. The human enzyme is encoded as a 34.6 kDa polypeptide that is post-translationally processed to generate two subunits of 
approx. 19.5 (a) and 15 (B) kDa. A charge enriched region is present at the predicted site where cleavage occurs. Using polyclonal antibodies against 
the a and /I subunits of rat liver asparaginase, we have shown that the human enzyme is similar in structure to the rat enzyme. 
Glycosylasparaginase; Lysosome; cDNA; Aspartylglucosaminuria; Glycoprotein degradation 
1. INTRODUCTION 
Glycosylasparaginase (EC 3.5.1.26) is a lysosomal 
amidase that cleaves the GlcNAc-Asn bond which joins 
oligosaccharides to the peptide of asparagine-linked 
glycoproteins [l]. The enzyme requires a free a-amino 
and carboxyl group on the Asn [2] and any cr-L-fucose 
at the 6-position of GlcNAc must be removed prior to 
GlcNAc-Asn hydrolysis [3]. Physiological and bio- 
chemical importance of asparaginase in the ordered, bi- 
directional degradation of asparagine-linked glyco- 
proteins [4] is evidenced by the occurrence of the inborn 
lysosomal storage disease aspartylglucosaminuria when 
there is a deficiency of the enzyme [5]. This disorder is 
almost exclusively localized to Finland where it has 
been estimated that approx. 1:26 000 are affected and 
as many as 1:40 in certain areas of the country are 
heterozygote carriers of the defective gene [6]. The 
disease is characterized by high intracellular and 
urinary levels of aspartylglucosamine and related 
glycopeptide fragments. Although early development 
of patients with the disorder is normal, they undergo a 
progressive mental and physical deterioration. 
We recently purified glycosylasparaginase to homo- 
geneity from rat liver and found it to have a native 
molecular mass of 49 kDa and to consist of two 
subunits of 24 and 20 kDa [7]. Baumann et al. [8] 
reported human asparaginase to be 60 kDa with three 
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subunits of 24,18 and 17 kDA, however, we have found 
the human and rat enzymes to be similar in structure. In 
the present report we describe the cloning and sequence 
analysis of a complete cDNA for human glycosylas- 
paraginase. The subunits of the enzyme are encoded by 
a single gene and therefore are generated post- 
translationally by proteolytic cleavage*. 
2. MATERIALS AND METHODS 
2.1. Biochemistry 
Rat liver glycosylasparaginase was purified as previously described 
[7]. Subunit-specific antisera were obtained by separating the (Y and j3 
subunits by SDS/PAGE and injecting homogenized gel pieces con- 
taming a single subunit into separate rabbits. A partial CNBr digest 
of gel slices containing the respective rat enzyme subunits was carried 
out [9]. The CNRr digest was separated by SDS/PAGE and blotted 
onto a PVDF membrane for sequencing (The Wistar Institute 
Microchemistry Core Facility, Philadelphia, PA, USA). Human 
glycosylasparaginase was partially purified from 5 g of liver. The 
tissue was minced and homogenized in 15 ml 0.05 M phosphate, pH 
7.0, containing 0.15 M NaCl and 2% Triton X-100. After centrifuga- 
tion for 10 min at 10 000 x g the supernatant was run through a Con- 
canavalin A and ACA-54 gel filtration step as described previously 
[7]. For immunodetection the enzyme was subjected to SDS/PAGE 
Phastgel g-25% and blotted onto a PVDF-membrane by diffusion at 
70°C for 3 h. The antigen was detected with a secondary an- 
tibody/alkaline phosphatase conjugate [lo]. N-glycanase treatment 
and enzyme activity determination were carried out as done previous- 
1Y 171. 
*We have noted a similar (Y and /3 subunit structure to exist for &TO- 
sylasparaginase from rat, mouse, pig and human liver, but in each 
case there is some variation in their masses. Therefore, we propose 
that the heavy and light subunits of this lysosomal amidase from the 
various species be referred to as (Y (heavy) and B (light) subunits. 
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2.2. PCR amplification and identification of a partial rat asparagi- 
nase clone 
Mixed oligonucleotide primers were synthesized (Penn State 
Biotechnology Institute) using amino acid sequence data from amino 
terminal analysis and a CNBr peptide of the fi subunit of rat liver 
asparaginase. Deoxyinosine was substituted at selected wobble 
(degenerate) positions to reduce the number of primer sequence mix- 
tures [l 11. PCR reactions were performed using the GeneAmp DNA 
Amplification Reagent Kit (Perkin-Elmer/Cetus) according to the 
manufacturer’s instructions with the 5’ (sense) and 3’ (antisense) 
primers at 0.5 CM each. The PCR template was 5 pg of first strand 
cDNA generated from random hexanucleotide primed rat liver po- 
ly(A) + mRNA. Thermal cycling was done in an automated 
heating/cooling block (DNA Thermal Cycler:Perkin-ElmerKetus) 
programmed for a temperature-step cycle of 92°C (1 min), 48’C (1 
min), and 72’C (2 min). A total of 40 cycles were performed with the 
72°C step extended to 15 min in the final cycle. Amplified fragments 
were resolved on a 10% polyacrylamide gel and either visualized with 
ethidium bromide or Southern blotted onto a nylon membrane 
(Amersham). Southern blots were hybridized with a mixed-sequence 
3 ‘-end labeled oligonucleotide probe synthesized from the amino acid 
sequence of a CNBr peptide predicted to reside between the sequences 
used for the 5 ’ and 3 ’ PCR primers. Fragments of interest were excis- 
ed from the gel, electroeluted and subcloned into M13mplW19 and 
pUC18 for sequence analysis and preparative growth [lo]. 
2.3. Northern blotting and isolation of a human glycosylasparaginase 
cDNA 
The PCR amplified fragment PCR/RLAsn. 1 was random primer 
labeled with [a-32P]dCTP and used to probe a Northern blot of rat 
liver and human placenta poly(A)+ mRNA. PCR/RLAsn.l was also 
random primer labeled with biotin-11-dUTP and used to screen a 
xgtll human placenta cDNA library (Clonetech) [lo]. Phage DNA 
was purified from a single putative positive clone and the cDNA insert 
subcloned into Ml3mp18/19 and pUCl8 for DNA sequencing and 
preparative growth. Nucleotide and protein sequences were analysed 
with the computer software DNA Strider [12]. 
3. RESULTS AND DISCUSSION 
3.1. Immunological and biochemical similarity of rat 
and human glycosylasparaginases 
Antisera against rat (I! and /3 subunits crossreacted 
with corresponding subunits of the human enzyme (Fig. 
1). Structural similarity between human and rat 
asparaginases was further verified by comparing loss of 
enzyme activity in relation to temperature- and pH- 
induced dissociation of human (Y and fl subunits in the 
presence of SDS as was done previously with purified 
1 2 3 4 5 
Fig. 1. Immunoblot of human glycosylasparaginase using antisera 
against rat enzyme subunits. A total of 0.06 U/ml of partially purified 
human enzyme (0.003 Wmg) was subjected to SDS/PAGE and 
immunoblotted as described in section 2. Lane 1: antisera against 
both subunits were used; 2 and 3: antiserum against 0 subunit; 4 and 
5: antiserum against (Y subunit. In lanes 3 and 5 the enzyme was 
pretreated with N-glycanase. 
rat liver enzyme [7]. The biochemical and physical 
behaviors of human asparaginase mimicked those of 
the rat in these experiments (data not shown). Two 
heterogeneous forms of human /3 subunits having 
masses of 17 and 18 kDa were specifically detected on 
a Western blot with antibody against the rat fl subunit 
(Fig. 1, lanes 1 and 2). These appear to be the same two 
light subunits reported in purified human asparaginase 
isolated by Baumann et al. [8]. After N-glycanase treat- 
ment only a single band of 15.5 kDa (lane 3) was detec- 
table. A single polypeptide having an N-linked oligosac- 
charide of variable sugar composition therefore would 
account for the heterogeneity in human fl subunits. The 
human cr subunit was specifically detected by antibody 
against rat CY subunit and had a mass of 23 kDa (lanes 
1 and 4) which decreased to 20.5 kDa after N-glycanase 
treatment (lane 5). Using similar biochemical and im- 
munological methods we have so far noted a basic (Y 
and 8 subunit structure to be common to lysosomal 
glycosylasparaginase from rat, human, mouse and pig 
(data not shown). 
3.2. PCR amplification of a partial rat asparaginase 
cDNA 
The strategy that was employed to obtain a DNA 
fragment encoding rat asparaginase gene sequences is 
outlined in Fig. 2. The correct mapping of the two 
CNBr sequences relative to the amino terminus was ac- 
complished by performing partial CNBr digests of the 
purified @ (20 kDa) subunit of rat asparaginase. Based 
on the size difference between the undigested p subunit 
and CNBr-2, it was predicted that the amplified frag- 
ment should be approx. 150-200 bp in length. Although 
attempts to selectively amplify the sequence between the 
two PCR primers appeared inconclusive from ethidium 
bromide stained gels (i.e. numerous distinct fragments 
were generated), the internal probe synthesized from 
CNBr-1 amino acid sequence hybridized to only a single 
band of approx. 200 bp on Southern blot hybridization 
of the reaction products. This fragment, designated 
PCR/RLAsn. 1, had an open reading frame 221 bp in 
length (Fig. 3). The deduced amino acid sequence from 
PCR1RLAsn.l was found to correspond to the collec- 
tive rat asparaginase protein sequence that aligned be- 
tween the two PCR primers. 
3.3. Isolation and characterization of a human 
placenta cDNA for glycosylasparaginase 
Northern blot analysis of rat liver and human placen- 
ta poly(A) + mRNA with the amplified fragment 
PCR/RLAsn. 1 identified an approx. 2.0 kb message in 
both species (Fig. 4). A second band of 1.7 kb was also 
observed in the rat sample that appears to be the 
predominant message based on signal intensities. Upon 
screening approx. IO6 pfu’s of the human placenta 
cDNA library with the biotin-labeled PCR/RLAsn. 1 
fragment, only a single putative positive clone 
441 
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peptide: (A) r+Temrimu (TV VBr-1 (C) CNBr-2 
Fig. 2. Amino acid sequences from the /3 subunit of rat liver glycosylasparaginase that were used for PCR amplification of a rat asparaginase 
cDNA. The bold underlined amino acid sequences from the N-terminus of the fi subunit of purified rat liver glycosylasparaginase (A) and one of 
its cyanogen bromide peptides [(C), CNBr-21 were selected to design the indicated 5’- and 3’-primers for PCR amplification of a rat cDNA 
fragment. The indicated DNA probe designed from a second cyanogen bromide peptide [(B), CNBr-1) was used to detect he rat cDNA fragment 
amplified by PCR between regions (A) and (C). 
V I H K T G Ii T A A G T S T N G L K F 
KWRLhl.1 G:T GTG ATT CAC AAG ACG GGA CAT ACT GCT GCT GGC ACA TCT ACA AAT GGT TTA AAA TTC 60 
5’4CRPrimea (S’)GTN GTI ATH CAY MI ACO') 
V V I H K T G H T A A G T S T N G L 
$6 A;A C:T GET C:T G:A G:A G:C T:A C:A A& C:T G:A GET G:A G& TiT G:T GiT G:C 120 
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Fig. 3. Sequence of the PCR amplification product PCR/RLAsn.l. The PCR primer and internal probe sequences that were used are given below 
the sequence of PCR/RLAsn. 1. The relevant protein sequence from the fi subunit of rat asparaginase that was used to construct he PCR primers 
and internal probe, and to establish the identity of the amplified fragment are also given. 
28s 
18s 
1 2 3 
Fig. 4. Northern blot analysis of rat and human mRNAs with 
PCR/RLAsn.l. mRNAs from rat liver (1.5 and 3.O~g, lanes 1 and 2) 
and human placenta (1.5 gg, lane 3) were electrophoresed and probed 
with “‘P-labeled PCR/RLAsn. 1. 
The 1.2 kb cDNA insert (HPAsn.6) that was retriev- 
ed from XHPAsn.6 contained an open reading frame of 
1065 bp (Fig. 5). The first in-frame methionine (ATG) 
encoded by HPAsn.6 was preceded by the sequence 
CAGGG that conforms to a concensus sequence for 
eukaryotic mRNAs by containing a purine in the - 3 
position relative to the initiation codon [13]. A stretch 
of amino acid (Ser-24 to Trp-44) downstream from 
Met-l was colinear with the amino terminal sequence 
from the CY subunit of the rat enzyme with only a single 
amino acid difference between the two species. The 23 
residue sequence ncompassing Met-l through Cys-23 is 
characteristic of a eukaryotic signal sequence suggesting 
the site of signal peptidase cleavage to be Cys-23/ 
Ser-24. This is supported by the weighted-matrices 
method of von Heijne [ 141. 
The deduced amino acid sequence from HPAsn.6 
revealed additional regions with sequence identity to rat 
asparaginase including the amino terminus of the P 
subunit, CNBr peptide sequences from the (Y and /3 
subunits, and the PCR amplified fragment PCR/ 
RLAsn.1 from the /3 subunit. Of the 131 amino acids 
that overlap between rat asparaginase protein/cDNA 
sequence and the human asparaginase clone HPAsn.6, 
(XHPAsn.6) hybridized to the PCR probe in the 
primary and subsequent screening rounds. 
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tcgcgctggtctcttcggtggtcaggg A!G GtG C:G dG TEG AiC TkG C:T GFG C:T CiC 60 
l" 
L P L v d 
G;G C;G T;T CiG CkC T:C CiG GtC CkA G;G Ck T:C TCC TGC CCT CTG CCC CTG GTC GTC ::O 
v 
BTWPFKNATEAAtf 
AAC ACT TGG CCC TTT AAG AAT GCA ACC GAA GCA GCG TGG AZG GtA TtA G:A T:T G:A Gk :iO 
T;T GtC CkG G:T GA- G?G G:G A& G:C T:T GtC A!G T:T G:G A&i GtG CiG T:T G:C Gk I:0 
A!G G:T Gk A:T A:T At!G G:T G:A GiiA GtA G:A Gk GiT Ck A:A Ch A;T Aha dT GtT iti 
A$T GET G:G GtA CL Ah G:A CiG GiA C:T A& A:A C:C A&i C:T TkA G:A GfiA GIG T& :%I 
T 8 X x T 
'RGFIIEDLSTSAS 
G:C A& A:A T:T GtT CiA AiT ATG GGG TTT ATC AAT GAA GAC TTA TCT ACC AGT GCT TCT % 
h 
CAA GCT CTT C:T T& G:T T!G C;T G:T C:G AiT Tk CiG C&4 A!T T:T TiG AiG A!T G;T 3:; 
A$A C:A G:T C:C T& Ah T:C T:C GEA CEC T:C Ah C:A C:T G:T A& TiA AiG CiG GiiT %I 
AgT C!T A& Ck A-A % 
c T L 
HIAAGTSTNGf 
CAT ATT GCT GCT GGT ACA TCT ACA AAT GGT ATA Ai& T:C $6 A;A 3% 
ii 
Y 
CAT G& C:T G;A G&i G:C T;A C:A AkA C:T G:A GtT G& G:C T:T GtT 2C G:T ACT GCA 780 
T x 251 
D T L 
GAAAATGUGDIL 
GGG GCA GCC GCA GCC ACT GGG AAT GGT GAT ATA TTG A!G C:C T:C CkG C:A A& T:C CiA 2s;; 
G:T G;A GiA T:C A!G A AGA GGA GAA GAT CCA ACC ATA GCT TGC CAA AAA GTG ATT TCA 29;; 
Y Y X 
RIQKHTPEFFGAV 
v 
AGA ATC CAG AAG CAT TTT CCA GAA TTC TTT GGG GCT GTT A;A T:T GtC ZT G;G A:T G& :;A 
AiT T:C GET GtT G:T T:C AtT Ak CiT T;A A:A T:T A:T CItG T!T A:T T;C A!G G:T T:T I::0 
NSEKNQPTEEKVDCI *t* 
AAT TCC GAA AAA AAT CAG CCA ACT GAG GAA AAA GTG GAC TGC ATC TAA tccatctttactqtc 
346 
1083 
aacatctqtatttaaaqaaqaaaqaaacaaaqqctqaaaaqqctqctcactctcatcatctaqtqttcctcatqtqttc 1162 
taaaqtctttttqtaaaataaac 1185 
Fig. 5. Nucleotide and deduced amino acid sequence of human placenta glycosylasparaginase clone HPAsn.6. The protein coding region is given 
in capital letters and untranslated sequences are in lowercase letters. The deduce-d amino acid sequences from Ser-24 to Trp-44 and from Thr-206 
to Ile-227 that are overscored with a double-line are homologous to the amino terminal sequence obtained from the (r and fl subunits of rat liver 
glycosylasparaginase, r spectively. The deduced amino acid sequence from Met-139 to Leu-154 that is overscored with a single line is homologous 
to a CNBr peptide sequence from the o subunit of rat glycosylasparaginase. The deduced amino acid sequences from Ala-251 to Leu-263 and from 
Arg-277 to W-304 are homologous to CNBr peptide sequences obtained from the B subunit of rat glycosylasparaginase. The sequence between 
the brackets is homologous to the DNA fragment PCR/RLAsn.l that was amplified from rat liver mRNA. Residues in bold print indicate 
differences between the deduced amino acid sequence of HPAsn.6 and the partial rat asparaginase sequence compiled from amino terminal 
analysis. CNBr peptides and PCR/RLAsn. 1. Amino acid residues with an X above were inconclusive during protein sequencing of the rat enzyme. 
Potential asparagine-linked glycosylation sites are indicated by a solid triangle. The vertical arrow shows the predicted site of cleavage by signal 
peptidase. The boxed sequence shows a hydrophilic region proposed to be susceptible to proteolytic cleavage. 
86% of the residues are identical. The presence of 
HPAsn.6 sequence homologous to both the (r and @ 
subunits of rat asparaginase suggests human asparag- 
inase is encoded as a 34.6 kDa polypeptide that is subse- 
quently processed to generate two fragments of approx. 
19.5 ((II subunit) and 15 kDa (p subunit). The predicted 
site of post-translational cleavage is a stretch of 11 
hydrophilic residues immediately upstream of the se- 
quence that corresponds to the amino terminus of the @ 
subunit of rat asparaginase (Pig. 6). Hydrophilic 
regions such as this have been proposed to be suscepti- 
ble to proteolytic hydrolysis in the lysosomes [151. Two 
Asn-linked glycosylation sites (Asnss and Asnsos) en- 
coded by HPAsn.6 are distributed such that each of the 
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Fig. 6. Hydrophilicity plot of human glycosylasparaginase [16]. 
Within the hydrophilic region between amino acid residues 195-205 is 
the site proposed to be cleaved by cathepsins to form mature o and /3 
subunits in the lysosomes. 
two subunits has the potential to be glycosylated. 
Asnsos in the sequence corresponding to the 15 kDa 
fragment may display heterogeneity in the structure of 
the attached oligosaccharide thereby resulting in the 
two immunologically related fragments hown in Fig. 1. 
This information on the biochemistry and molecular 
biology of human glycosylasparaginase can now be us- 
ed to characterize the mutation(s) responsible for aspar- 
tylglucosaminuria. 
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